Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 110 | 96 | 93 | 762 | 56 |
| Cost of Goods | 28 | 24 | 39 | 38 | 15 |
| Gross Profit | 82 | 72 | 54 | 725 | 42 |
| Operating Expenses | 1,009 | 772 | 943 | 935 | 910 |
| Operating Income | -927 | -700 | -889 | -210 | -868 |
| Interest Expense | 68 | 0 | 1 | -1 | 6 |
| Other Income | -1 | -1 | 0 | -680 | 5 |
| Pre-tax Income | -997 | -702 | -890 | -889 | -869 |
| Net Income Continuous | -997 | -702 | -890 | -889 | -869 |
| Net Income | $-997 | $-702 | $-890 | $-889 | $-869 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
| EBITDA(a) | $-909 | $-685 | $-872 | $-861 | $-849 |